FDA Warns Public Against Falsified Dr Alfred Capsules Adulterated with Sildenafil Citrate
The Food and Drugs Authority (FDA) has issued a public warning about the circulation of falsified Dr Alfred Capsules, a dietary supplement for male vitality, on various social media platforms.
In a public release dated September 9, 2026, the FDA stated that the capsules in question have not been registered by the Authority.
Following regulatory intelligence and subsequent enforcement operations, the FDA identified an organised syndicate operating in Accra and Suhum that manufactures and distributes the falsified products across the country.
Two suspects linked to the illicit activity are currently on police enquiry bail assisting with ongoing investigations.
The falsified Dr Alfred Capsules are produced in unauthorised, unregulated and unhygienic environments and pose a critical public health risk.
Laboratory analysis by the FDA Centre for Laboratory Services and Research confirmed that these falsified variants have been adulterated with sildenafil citrate, an allopathic drug substance.
Sildenafil citrate is a phosphodiesterase type 5 (PDE5) inhibitor and a prescription-only medicine used to treat erectile dysfunction in men, as well as pulmonary arterial hypertension. It is an undeclared drug substance in the falsified product.
The genuine registered product is manufactured by CV Al Manar Herbafit of Yogyakarta, Indonesia, and registered by Unateus Ghana Limited as a food supplement. The registered product does not contain sildenafil citrate.
The FDA highlighted clear differences between the registered and falsified products, including packaging quality, batch numbers, security seals, capsule shell colours and the colour of the powder content.
The Authority advised the public to desist from purchasing medications, herbal remedies or dietary supplements from unverified online networks and social media handles.
All pharmacies, herbal shops and distributors are directed to immediately inspect their stock and report any suspicion of falsified products to the FDA.
Anyone in possession of these falsified products must immediately return them to the nearest FDA regional office across the country.
The FDA continues its market surveillance and digital monitoring to ensure all remnants of these illicit falsified variants are completely removed from circulation.
Anyone with information on the falsified Dr Alfred Capsules or any other suspected falsified products is urged to report to the FDA through its official channels.
